Discover HUMIRA, a biologic treatment option for adults with moderate to severe chronic plaque psoriasis (PS). See Important Safety Information & BOXED WARNING and full Prescribing Information.

Plaque Psoriasis: HUMIRA is indicated for the treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other …

May 5, 2025 · Humira (adalimumab) is a brand-name subcutaneous injection prescribed for plaque psoriasis. This article covers topics such as side effects, cost, and how Humira works.

Mar 24, 2025 · What is Humira? Humira (also know by its generic name adalimumab) is a TNF-alpha inhibitor biologic medication approved by the FDA in October 2005 for use in adult patients to treat …

Dec 23, 2025 · The recommended subcutaneous dosage of HUMIRA for adult patients with plaque psoriasis (Ps) or uveitis (UV) is an initial dose of 80 mg, followed by 40 mg given every other week …

Humira (adalimumab) is a biologic medication approved by the U.S. Food and Drug Administration (FDA) for treating moderate to severe psoriasis in adults.

Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. …

Plaque Psoriasis Indicated for treatment of moderate-to-severe chronic plaque psoriasis (Ps) in candidates for systemic therapy or phototherapy and when systemic therapies are inappropriate

Nov 13, 2024 · Find patient medical information for Adalimumab (Humira) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Humira (also referred to by its generic name, adalimumab) is a biologic medication that is used to treat severe psoriasis and/or psoriatic arthritis. Biologics are modern medications that are made using …